iSpecimen (ISPC) Liabilities and Shareholders Equity (2020 - 2026)

iSpecimen (ISPC) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $6.6 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 3.41% year-over-year to $6.6 million; the TTM figure through Mar 2026 stood at $31.2 million (down 20.8% YoY), while the FY2025 annual figure was $9.5 million, up 1.94% from the prior year.
• Liabilities and Shareholders Equity came in at $6.6 million for Q1 2026 at iSpecimen, down from $9.5 million in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $33.3 million in Q1 2022, with the low at $6.0 million in Q2 2025.
• Average Liabilities and Shareholders Equity over 5 years is $15.9 million, with a median of $12.5 million recorded in 2024.
• Across the five-year window, Liabilities and Shareholders Equity jumped 58.55% in 2022 and sank 49.3% in 2025, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $24.6 million in 2022, then plunged by 35.74% to $15.8 million in 2023, then plunged by 40.89% to $9.4 million in 2024, then rose by 1.94% to $9.5 million in 2025, then plunged by 30.65% to $6.6 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $6.6 million, $9.5 million, and $9.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.